Home > Publications Database > Alzheimer's Disease Risk Gene SORL1 Promotes Receptiveness of Human Microglia to Pro-Inflammatory Stimuli. > print |
001 | 276822 | ||
005 | 20250323000854.0 | ||
024 | 7 | _ | |a 10.1002/glia.24659 |2 doi |
024 | 7 | _ | |a pmid:39688327 |2 pmid |
024 | 7 | _ | |a pmc:PMC11845846 |2 pmc |
024 | 7 | _ | |a 0894-1491 |2 ISSN |
024 | 7 | _ | |a 1098-1136 |2 ISSN |
024 | 7 | _ | |a altmetric:172177084 |2 altmetric |
037 | _ | _ | |a DZNE-2025-00335 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Ovesen, Peter Lund |0 0000-0001-8801-4711 |b 0 |
245 | _ | _ | |a Alzheimer's Disease Risk Gene SORL1 Promotes Receptiveness of Human Microglia to Pro-Inflammatory Stimuli. |
260 | _ | _ | |a Bognor Regis [u.a.] |c 2025 |b Wiley-Liss |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1740387594_21779 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Sorting protein-related receptor containing class A repeats (SORLA) is an intracellular trafficking receptor encoded by the Alzheimer's disease (AD) gene SORL1 (sortilin-related receptor 1). Recent findings argue that altered expression in microglia may underlie the genome-wide risk of AD seen with some SORL1 gene variants, however, the functional significance of the receptor in microglia remains poorly explained. Using unbiased omics and targeted functional analyses in iPSC-based human microglia, we identified a crucial role for SORLA in sensitizing microglia to pro-inflammatory stimuli. We show that SORLA acts as a sorting factor for the pattern recognition receptor CD14, directing CD14 exposure on the cell surface and priming microglia to stimulation by pro-inflammatory factors. Loss of SORLA in gene-targeted microglia impairs proper CD14 sorting and blunts pro-inflammatory responses. Our studies indicate an important role for SORLA in shaping the inflammatory brain milieu, a biological process important to local immune responses in AD. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a Alzheimer's disease |2 Other |
650 | _ | 7 | |a SORLA |2 Other |
650 | _ | 7 | |a VPS10P domain receptors |2 Other |
650 | _ | 7 | |a brain inflammation |2 Other |
650 | _ | 7 | |a microglia |2 Other |
650 | _ | 7 | |a SORL1 protein, human |2 NLM Chemicals |
650 | _ | 7 | |a LDL-Receptor Related Proteins |2 NLM Chemicals |
650 | _ | 7 | |a Membrane Transport Proteins |2 NLM Chemicals |
650 | _ | 7 | |a Lipopolysaccharide Receptors |2 NLM Chemicals |
650 | _ | 7 | |a CD14 protein, human |2 NLM Chemicals |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Microglia: metabolism |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: genetics |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: metabolism |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: pathology |2 MeSH |
650 | _ | 2 | |a LDL-Receptor Related Proteins: genetics |2 MeSH |
650 | _ | 2 | |a LDL-Receptor Related Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Membrane Transport Proteins: genetics |2 MeSH |
650 | _ | 2 | |a Membrane Transport Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Lipopolysaccharide Receptors: metabolism |2 MeSH |
650 | _ | 2 | |a Lipopolysaccharide Receptors: genetics |2 MeSH |
650 | _ | 2 | |a Induced Pluripotent Stem Cells: metabolism |2 MeSH |
650 | _ | 2 | |a Inflammation: metabolism |2 MeSH |
650 | _ | 2 | |a Inflammation: genetics |2 MeSH |
700 | 1 | _ | |a Juul-Madsen, Kristian |b 1 |
700 | 1 | _ | |a Telugu, Narasimha S |b 2 |
700 | 1 | _ | |a Schmidt, Vanessa |b 3 |
700 | 1 | _ | |a Frahm, Silke |b 4 |
700 | 1 | _ | |a Radbruch, Helena |b 5 |
700 | 1 | _ | |a Louth, Emma Louise |b 6 |
700 | 1 | _ | |a Korshøj, Anders Rosendal |b 7 |
700 | 1 | _ | |a Heppner, Frank L |0 P:(DE-2719)2812386 |b 8 |
700 | 1 | _ | |a Diecke, Sebastian |b 9 |
700 | 1 | _ | |a Kettenmann, Helmut |0 0000-0001-8208-0291 |b 10 |
700 | 1 | _ | |a Willnow, Thomas E |b 11 |
773 | _ | _ | |a 10.1002/glia.24659 |g Vol. 73, no. 4, p. 857 - 872 |0 PERI:(DE-600)1474828-9 |n 4 |p 857 - 872 |t Glia |v 73 |y 2025 |x 0894-1491 |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/276822/files/DZNE-2025-00335.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/276822/files/DZNE-2025-00335.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:276822 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2812386 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-06 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b GLIA : 2022 |d 2025-01-06 |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2025-01-06 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-06 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-06 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b GLIA : 2022 |d 2025-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-06 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2025-01-06 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-06 |
920 | 1 | _ | |0 I:(DE-2719)1810007 |k AG Heppner |l Neuroimmunology |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1810007 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|